Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAP - Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders

NCT02500602 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02500602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02500602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAP - Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2016
Completion date
December 16, 2019
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorders, posttraumatic stress disorder